The objectives of this study were to compare oestrous synchronization expression and conception rate following timed artificial insemination (TAI) with frozen–thawed X‐sexed or unsexed semen in dairy and beef cows. For this study, 227 cows (dairy, n = 130 and beef, n = 97) were assigned to a 9‐day Ovsynch + controlled intravaginal drug release (CIDR) protocol. All cows were TAI using X‐sexed or unsexed semen from 8 sires. Each semen type was obtained from 4 sires [2 dairy (Holstein Friesian) and 2 beef (Angus)]. Pregnancy detection was performed on Days 35, 65 and 95 following TAI by transrectal ultrasonography and hand palpation. The proportion of oestrus expression was higher in dairy (85.3%) cows compared with beef (65.0%) cows (p < .05). Overall, dairy (X‐sexed, 61.9% and unsexed, 62.0%) cows had greater conception rates on Day 35 compared to beef (X‐sexed, 56.0% and unsexed, 52.2%) cows (p < .05). Concurrently, on Day 95, overall conception rates in dairy (X‐sexed, 41.4% and unsexed, 48.5%) cows were greater than beef (X‐sexed, 38.0% and unsexed, 37.0%) cows (p < .05). Pregnancy/embryo losses between Days 35 and 65 in dairy (X‐sexed, 33.3% and unsexed, 18.2%) cows and beef (X‐sexed, 28.6% and unsexed, 29.2%) cows were recorded (p < .05). Dairy (X‐sexed, 7.7% and unsexed, 8.3%) cows had higher incidence of pregnancy losses between Days 66 and 95 when compared to beef (X‐sexed, 5.0% and unsexed, 0.0%) cows (p < .05). Oestrous expression and conception rates in dairy and beef cows were satisfactory. Advanced reproductive biotechnologies can successfully utilize gender‐ablated semen in organized emerging cattle farming systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.